SlideShare a Scribd company logo
1 of 17
Download to read offline
www.piqpharma.com
PIQ-PHARMA
CONTRACT MANUFACTURING
2
Mission of PIQ-PHARMA group of companies
We take care of raising the quality of life and improvement
of health of people of various generations by creating
innovative, highly effective drugs.
3
History
1994 Company’s foundation (Moscow)
1995 – 2006 Market launch of main drug products
2006 Development of Medical Representatives Service
2009 Launching of manufacturing plant of finished
pharmaceutical products PIQ-PHARMA PRO LLC (Leningrad
region)
2011 Launching of manufacturing plant of active pharmaceutical
ingredients PIQ-PHARMA CHEM LLC (Belgorod)
2012 Taking possession and start of modernization for
manufacturing plant of finished pharmaceutical products PIQ-
PHARMA LEK LLC (Belgorod region)
2013 Modernization of PIQ-PHARMA CHEM LLC (Belgorod).
Development of technological laboratory (Moscow)
2015 Bringing into service manufacturing plant PIQ-PHARMA
LEK LLC after modernization (Belgorod region)
4
Major competences of PIQ-PHARMA group of companies
R&D
PRE-CLINICAL
AND CLINICAL
TRIALS
REGISTRATION
PRODUCTION
PROMOTION
5
Core targets
Core competences of PIQ-PHARMA Group of companies allowing to grow faster than the
market average.
0
5 000
10 000
15 000
20 000
25 000
30 000
35 000
40 000
45 000
50 000
2007 2008 2009 2010 2011 2012 2013 2014
ThousandUSD
Sales volume, thousand USD
0
1 000
2 000
3 000
4 000
5 000
6 000
2007 2008 2009 2010 2011 2012 2013 2014Thousandpacks
Sales volume, thousand packs
6
Structure of PIQ-PHARMA group of companies
Total number of employees is
more than 500 people
Manufacturing of finished
pharmaceutical products
PIQ-PHARMA PRO
Leningrad region
API’s
production
PIQ-PHARMA CHEM
Belgorod
Pharmaceutical
warehouse
Moscow region
Managing company
PIQ-PHARMA LLC
Moscow
PIQ-PHARMA LEK
Belgorod region
Technological
laboratory
Moscow
7
Manufacturing plant of finished pharmaceutical products PIQ-PHARMA LEK LLC
started its operation at industrial park “Severniy” in Belgorod region in 2015.
Dosage form production
- Designed and built according to GMP rules
- Only leading suppliers for manufacturing equipment:
IMA (Italy); KILIAN (Germany); ROMACO (Italy)
- Big modern warehouse
- Effective engineering systems
- Highly professional staff
Conforms to GMP requirements
8
Dosage form production
Finished pharmaceutical products of PIQ-PHARMA Group of Companies are
produced at its own production enterprise PIQ-PHARMA PRO LLC located in
Leningrad region.
Production capacity (annually):
● 4 million units of non-sterile liquid-
dosage forms
9
Manufacturing plant PIQ-PHARMA CHEM LLC (Belgorod) produces active pharmaceutical
ingredients for PIQ-PHARMA group of companies. Production of a new pharmaceutical
substances – D,L-hopantenic acid, ipidacrine – was developed in 2012-2014.
Production capacity (on annual basis):
API’s production
year Pantogam
API, MT
D,L-hopantenate
API, MT
2012 24 0,1
2013 31 1,1
2014 32 2,2
2015 34 4
10
Was founded in Moscow in 2013. Laboratory is well equipped for producing of solid
dosage forms and liquid oral forms (solutions, syrups, suspensions, emulsions).
Technological laboratory
Laboratory’s tasks:
● Development and upgrading of drugs;
● Manufacturing of small batches of drugs
for pre-clinical studies;
● Scaling up of processes for industrial
equipment.
● Holding of educational workshops
11
Pharmaceutical warehouse of PIQ-PHARMA, equipped in compliance with licensing and
certification requirements, ensure proper safety storage of finished products in line with
current regulations.
Pharmaceutical warehouse
Warehouse’s employees maintain a high
level of a customer service:
- timely and accurate release and delivery of
products;
- individual approach for every customer;
- implementation of high-tech methods for
arrangement of warehouse activities.
12
Production capacities of «PIQ-PHARMA-LEK» for solid dosage forms
Production is in compliance with international GMP rules
Designed Capacities 500 mln tablets / annually
100 mln capsules / annually
Our own consumption 150 mln tablets / annually
30 mln capsules / annually
Vacant production capacities for
contract manufacturing
350 mln tablets / annually
70 mln capsules / annually
13
Production Capacities of«PIQ-PHARMA-LEK» for liquid dosage forms
We are looking for a reliable partner to start up our liquid dosage
forms production
Production of non-sterile liquid forms
(bottles 25 ml; 50 ml; 100 ml; 150 ml; 250 ml)
Project start up in 2017
Designed capacities 10 mln. bottles / annually
Vacant production capacities for contract
manufacturing
10 mln. bottles / annually
14
Product portfolio
● 9 brands (the most are innovative).
● 18 dosage forms
● Pharmacological groups:
- neurological,
- metabolic,
- cardiological.
● Main areas of application:
pediatrics, psychoneurology, endocrinology, cardiology, psychiatrics.
● Dosage forms:
tablets, capsules, solutions for oral use, syrups, injectables.
15
Russia
Ukraine
Azerbaijan
Moldova
Belarus
Kazakhstan
Kyrgyzstan
Armenia
Uzbekistan
Georgia
Tajikistan
Markets
PIQ-PHARMA expands sales market for own production constantly. At the moment
products are available in almost all CIS and near-abroad countries.
16
Our partners
● Scientific, R&D, medical centers
● Universities
● KOLs
● Authorities responsible for regulation of
pharmaceutical market
● Patent offices
● Consulting and marketing companies
● CROs
● Leading national and regional distributors
(Protek, Katren, Puls, Rosta, Alliance Healthcare,
Pharmkomplekt, Implozia)
● Russian and International manufacturers and
suppliers of raw materials
17
Contacts
Headquarter:
25/1, pereulok Oruzheyniy, Moscow, 125047
www.piqpharma.com
E-mail: info@pikfarma.ru
tel.: +7-495-925-57-00
Video channel: Youtube.com/pikfarma
17

More Related Content

Similar to PIQ-PHARMA Contract manufacturing

Herbion Coporate Presentation
Herbion Coporate PresentationHerbion Coporate Presentation
Herbion Coporate Presentation
Rana Nouman
 
Nextar presentation
Nextar presentationNextar presentation
Nextar presentation
nextar-c-s
 
SABIC-Healthcare-Brochure-2019_tcm1010-21230.pdf
SABIC-Healthcare-Brochure-2019_tcm1010-21230.pdfSABIC-Healthcare-Brochure-2019_tcm1010-21230.pdf
SABIC-Healthcare-Brochure-2019_tcm1010-21230.pdf
malek12
 
IriSys Profile Presentation widescreen V.2.3
IriSys Profile Presentation widescreen V.2.3IriSys Profile Presentation widescreen V.2.3
IriSys Profile Presentation widescreen V.2.3
Chance Willkomm
 
Financial analysis of venus remedies
Financial analysis of venus remediesFinancial analysis of venus remedies
Financial analysis of venus remedies
pankajkumar3480
 
Latitude Pharmaceuticals Overview
Latitude Pharmaceuticals OverviewLatitude Pharmaceuticals Overview
Latitude Pharmaceuticals Overview
Matthew Singer
 

Similar to PIQ-PHARMA Contract manufacturing (20)

About Aurena
About AurenaAbout Aurena
About Aurena
 
Herbion Coporate Presentation
Herbion Coporate PresentationHerbion Coporate Presentation
Herbion Coporate Presentation
 
Ranvver sharma ppt
Ranvver sharma pptRanvver sharma ppt
Ranvver sharma ppt
 
United laboratories india
United laboratories indiaUnited laboratories india
United laboratories india
 
Tour prav
Tour pravTour prav
Tour prav
 
R&D Presentation .PPT
R&D Presentation .PPTR&D Presentation .PPT
R&D Presentation .PPT
 
Pharma third party manufacturing companies in Baddi | Pharmaadda
Pharma third party manufacturing companies in Baddi | PharmaaddaPharma third party manufacturing companies in Baddi | Pharmaadda
Pharma third party manufacturing companies in Baddi | Pharmaadda
 
Sanitelle
SanitelleSanitelle
Sanitelle
 
Nextar presentation
Nextar presentationNextar presentation
Nextar presentation
 
Synthon, The Value Chain of a specialty pharmaceutical company
Synthon, The Value Chain of a specialty pharmaceutical companySynthon, The Value Chain of a specialty pharmaceutical company
Synthon, The Value Chain of a specialty pharmaceutical company
 
Ziska pharmaceuticals
Ziska pharmaceuticalsZiska pharmaceuticals
Ziska pharmaceuticals
 
SABIC-Healthcare-Brochure-2019_tcm1010-21230.pdf
SABIC-Healthcare-Brochure-2019_tcm1010-21230.pdfSABIC-Healthcare-Brochure-2019_tcm1010-21230.pdf
SABIC-Healthcare-Brochure-2019_tcm1010-21230.pdf
 
IriSys Profile Presentation widescreen V.2.3
IriSys Profile Presentation widescreen V.2.3IriSys Profile Presentation widescreen V.2.3
IriSys Profile Presentation widescreen V.2.3
 
Ppt
PptPpt
Ppt
 
Marketing mix Analysis
Marketing mix AnalysisMarketing mix Analysis
Marketing mix Analysis
 
Financial analysis of venus remedies
Financial analysis of venus remediesFinancial analysis of venus remedies
Financial analysis of venus remedies
 
C1 technology updates October 2018
C1 technology updates October 2018C1 technology updates October 2018
C1 technology updates October 2018
 
Latitude Pharmaceuticals Overview
Latitude Pharmaceuticals OverviewLatitude Pharmaceuticals Overview
Latitude Pharmaceuticals Overview
 
45337850 mgt-company-analysis-beximco-pharma
45337850 mgt-company-analysis-beximco-pharma45337850 mgt-company-analysis-beximco-pharma
45337850 mgt-company-analysis-beximco-pharma
 
List of pharma companies in Indore | Pharmaadda
List of pharma companies in Indore | PharmaaddaList of pharma companies in Indore | Pharmaadda
List of pharma companies in Indore | Pharmaadda
 

Recently uploaded

Challenges and Opportunities: A Qualitative Study on Tax Compliance in Pakistan
Challenges and Opportunities: A Qualitative Study on Tax Compliance in PakistanChallenges and Opportunities: A Qualitative Study on Tax Compliance in Pakistan
Challenges and Opportunities: A Qualitative Study on Tax Compliance in Pakistan
vineshkumarsajnani12
 
Contact +971581248768 for 100% original and safe abortion pills available for...
Contact +971581248768 for 100% original and safe abortion pills available for...Contact +971581248768 for 100% original and safe abortion pills available for...
Contact +971581248768 for 100% original and safe abortion pills available for...
DUBAI (+971)581248768 BUY ABORTION PILLS IN ABU dhabi...Qatar
 

Recently uploaded (20)

Falcon Invoice Discounting: Aviate Your Cash Flow Challenges
Falcon Invoice Discounting: Aviate Your Cash Flow ChallengesFalcon Invoice Discounting: Aviate Your Cash Flow Challenges
Falcon Invoice Discounting: Aviate Your Cash Flow Challenges
 
Falcon Invoice Discounting: The best investment platform in india for investors
Falcon Invoice Discounting: The best investment platform in india for investorsFalcon Invoice Discounting: The best investment platform in india for investors
Falcon Invoice Discounting: The best investment platform in india for investors
 
Thompson_Taylor_MBBS_PB1_2024-03 (1)- Project & Portfolio 2.pptx
Thompson_Taylor_MBBS_PB1_2024-03 (1)- Project & Portfolio 2.pptxThompson_Taylor_MBBS_PB1_2024-03 (1)- Project & Portfolio 2.pptx
Thompson_Taylor_MBBS_PB1_2024-03 (1)- Project & Portfolio 2.pptx
 
WheelTug Short Pitch Deck 2024 | Byond Insights
WheelTug Short Pitch Deck 2024 | Byond InsightsWheelTug Short Pitch Deck 2024 | Byond Insights
WheelTug Short Pitch Deck 2024 | Byond Insights
 
Falcon Invoice Discounting: Unlock Your Business Potential
Falcon Invoice Discounting: Unlock Your Business PotentialFalcon Invoice Discounting: Unlock Your Business Potential
Falcon Invoice Discounting: Unlock Your Business Potential
 
SEO Case Study: How I Increased SEO Traffic & Ranking by 50-60% in 6 Months
SEO Case Study: How I Increased SEO Traffic & Ranking by 50-60%  in 6 MonthsSEO Case Study: How I Increased SEO Traffic & Ranking by 50-60%  in 6 Months
SEO Case Study: How I Increased SEO Traffic & Ranking by 50-60% in 6 Months
 
The Vietnam Believer Newsletter_May 13th, 2024_ENVol. 007.pdf
The Vietnam Believer Newsletter_May 13th, 2024_ENVol. 007.pdfThe Vietnam Believer Newsletter_May 13th, 2024_ENVol. 007.pdf
The Vietnam Believer Newsletter_May 13th, 2024_ENVol. 007.pdf
 
Pre Engineered Building Manufacturers Hyderabad.pptx
Pre Engineered  Building Manufacturers Hyderabad.pptxPre Engineered  Building Manufacturers Hyderabad.pptx
Pre Engineered Building Manufacturers Hyderabad.pptx
 
Challenges and Opportunities: A Qualitative Study on Tax Compliance in Pakistan
Challenges and Opportunities: A Qualitative Study on Tax Compliance in PakistanChallenges and Opportunities: A Qualitative Study on Tax Compliance in Pakistan
Challenges and Opportunities: A Qualitative Study on Tax Compliance in Pakistan
 
UJJAIN CALL GIRL ❤ 8272964427❤ CALL GIRLS IN UJJAIN ESCORTS SERVICE PROVIDE
UJJAIN CALL GIRL ❤ 8272964427❤ CALL GIRLS IN UJJAIN ESCORTS SERVICE PROVIDEUJJAIN CALL GIRL ❤ 8272964427❤ CALL GIRLS IN UJJAIN ESCORTS SERVICE PROVIDE
UJJAIN CALL GIRL ❤ 8272964427❤ CALL GIRLS IN UJJAIN ESCORTS SERVICE PROVIDE
 
Goal Presentation_NEW EMPLOYEE_NETAPS FOUNDATION.pptx
Goal Presentation_NEW EMPLOYEE_NETAPS FOUNDATION.pptxGoal Presentation_NEW EMPLOYEE_NETAPS FOUNDATION.pptx
Goal Presentation_NEW EMPLOYEE_NETAPS FOUNDATION.pptx
 
Understanding Financial Accounting 3rd Canadian Edition by Christopher D. Bur...
Understanding Financial Accounting 3rd Canadian Edition by Christopher D. Bur...Understanding Financial Accounting 3rd Canadian Edition by Christopher D. Bur...
Understanding Financial Accounting 3rd Canadian Edition by Christopher D. Bur...
 
Contact +971581248768 for 100% original and safe abortion pills available for...
Contact +971581248768 for 100% original and safe abortion pills available for...Contact +971581248768 for 100% original and safe abortion pills available for...
Contact +971581248768 for 100% original and safe abortion pills available for...
 
Putting the SPARK into Virtual Training.pptx
Putting the SPARK into Virtual Training.pptxPutting the SPARK into Virtual Training.pptx
Putting the SPARK into Virtual Training.pptx
 
Progress Report - Oracle's OCI Analyst Summit 2024
Progress Report - Oracle's OCI Analyst Summit 2024Progress Report - Oracle's OCI Analyst Summit 2024
Progress Report - Oracle's OCI Analyst Summit 2024
 
Ital Liptz - all about Itai Liptz. news.
Ital Liptz - all about Itai Liptz. news.Ital Liptz - all about Itai Liptz. news.
Ital Liptz - all about Itai Liptz. news.
 
Marel Q1 2024 Investor Presentation from May 8, 2024
Marel Q1 2024 Investor Presentation from May 8, 2024Marel Q1 2024 Investor Presentation from May 8, 2024
Marel Q1 2024 Investor Presentation from May 8, 2024
 
The Art of Decision-Making: Navigating Complexity and Uncertainty
The Art of Decision-Making: Navigating Complexity and UncertaintyThe Art of Decision-Making: Navigating Complexity and Uncertainty
The Art of Decision-Making: Navigating Complexity and Uncertainty
 
A DAY IN THE LIFE OF A SALESPERSON .pptx
A DAY IN THE LIFE OF A SALESPERSON .pptxA DAY IN THE LIFE OF A SALESPERSON .pptx
A DAY IN THE LIFE OF A SALESPERSON .pptx
 
Horngren’s Cost Accounting A Managerial Emphasis, Canadian 9th edition soluti...
Horngren’s Cost Accounting A Managerial Emphasis, Canadian 9th edition soluti...Horngren’s Cost Accounting A Managerial Emphasis, Canadian 9th edition soluti...
Horngren’s Cost Accounting A Managerial Emphasis, Canadian 9th edition soluti...
 

PIQ-PHARMA Contract manufacturing

  • 2. 2 Mission of PIQ-PHARMA group of companies We take care of raising the quality of life and improvement of health of people of various generations by creating innovative, highly effective drugs.
  • 3. 3 History 1994 Company’s foundation (Moscow) 1995 – 2006 Market launch of main drug products 2006 Development of Medical Representatives Service 2009 Launching of manufacturing plant of finished pharmaceutical products PIQ-PHARMA PRO LLC (Leningrad region) 2011 Launching of manufacturing plant of active pharmaceutical ingredients PIQ-PHARMA CHEM LLC (Belgorod) 2012 Taking possession and start of modernization for manufacturing plant of finished pharmaceutical products PIQ- PHARMA LEK LLC (Belgorod region) 2013 Modernization of PIQ-PHARMA CHEM LLC (Belgorod). Development of technological laboratory (Moscow) 2015 Bringing into service manufacturing plant PIQ-PHARMA LEK LLC after modernization (Belgorod region)
  • 4. 4 Major competences of PIQ-PHARMA group of companies R&D PRE-CLINICAL AND CLINICAL TRIALS REGISTRATION PRODUCTION PROMOTION
  • 5. 5 Core targets Core competences of PIQ-PHARMA Group of companies allowing to grow faster than the market average. 0 5 000 10 000 15 000 20 000 25 000 30 000 35 000 40 000 45 000 50 000 2007 2008 2009 2010 2011 2012 2013 2014 ThousandUSD Sales volume, thousand USD 0 1 000 2 000 3 000 4 000 5 000 6 000 2007 2008 2009 2010 2011 2012 2013 2014Thousandpacks Sales volume, thousand packs
  • 6. 6 Structure of PIQ-PHARMA group of companies Total number of employees is more than 500 people Manufacturing of finished pharmaceutical products PIQ-PHARMA PRO Leningrad region API’s production PIQ-PHARMA CHEM Belgorod Pharmaceutical warehouse Moscow region Managing company PIQ-PHARMA LLC Moscow PIQ-PHARMA LEK Belgorod region Technological laboratory Moscow
  • 7. 7 Manufacturing plant of finished pharmaceutical products PIQ-PHARMA LEK LLC started its operation at industrial park “Severniy” in Belgorod region in 2015. Dosage form production - Designed and built according to GMP rules - Only leading suppliers for manufacturing equipment: IMA (Italy); KILIAN (Germany); ROMACO (Italy) - Big modern warehouse - Effective engineering systems - Highly professional staff Conforms to GMP requirements
  • 8. 8 Dosage form production Finished pharmaceutical products of PIQ-PHARMA Group of Companies are produced at its own production enterprise PIQ-PHARMA PRO LLC located in Leningrad region. Production capacity (annually): ● 4 million units of non-sterile liquid- dosage forms
  • 9. 9 Manufacturing plant PIQ-PHARMA CHEM LLC (Belgorod) produces active pharmaceutical ingredients for PIQ-PHARMA group of companies. Production of a new pharmaceutical substances – D,L-hopantenic acid, ipidacrine – was developed in 2012-2014. Production capacity (on annual basis): API’s production year Pantogam API, MT D,L-hopantenate API, MT 2012 24 0,1 2013 31 1,1 2014 32 2,2 2015 34 4
  • 10. 10 Was founded in Moscow in 2013. Laboratory is well equipped for producing of solid dosage forms and liquid oral forms (solutions, syrups, suspensions, emulsions). Technological laboratory Laboratory’s tasks: ● Development and upgrading of drugs; ● Manufacturing of small batches of drugs for pre-clinical studies; ● Scaling up of processes for industrial equipment. ● Holding of educational workshops
  • 11. 11 Pharmaceutical warehouse of PIQ-PHARMA, equipped in compliance with licensing and certification requirements, ensure proper safety storage of finished products in line with current regulations. Pharmaceutical warehouse Warehouse’s employees maintain a high level of a customer service: - timely and accurate release and delivery of products; - individual approach for every customer; - implementation of high-tech methods for arrangement of warehouse activities.
  • 12. 12 Production capacities of «PIQ-PHARMA-LEK» for solid dosage forms Production is in compliance with international GMP rules Designed Capacities 500 mln tablets / annually 100 mln capsules / annually Our own consumption 150 mln tablets / annually 30 mln capsules / annually Vacant production capacities for contract manufacturing 350 mln tablets / annually 70 mln capsules / annually
  • 13. 13 Production Capacities of«PIQ-PHARMA-LEK» for liquid dosage forms We are looking for a reliable partner to start up our liquid dosage forms production Production of non-sterile liquid forms (bottles 25 ml; 50 ml; 100 ml; 150 ml; 250 ml) Project start up in 2017 Designed capacities 10 mln. bottles / annually Vacant production capacities for contract manufacturing 10 mln. bottles / annually
  • 14. 14 Product portfolio ● 9 brands (the most are innovative). ● 18 dosage forms ● Pharmacological groups: - neurological, - metabolic, - cardiological. ● Main areas of application: pediatrics, psychoneurology, endocrinology, cardiology, psychiatrics. ● Dosage forms: tablets, capsules, solutions for oral use, syrups, injectables.
  • 15. 15 Russia Ukraine Azerbaijan Moldova Belarus Kazakhstan Kyrgyzstan Armenia Uzbekistan Georgia Tajikistan Markets PIQ-PHARMA expands sales market for own production constantly. At the moment products are available in almost all CIS and near-abroad countries.
  • 16. 16 Our partners ● Scientific, R&D, medical centers ● Universities ● KOLs ● Authorities responsible for regulation of pharmaceutical market ● Patent offices ● Consulting and marketing companies ● CROs ● Leading national and regional distributors (Protek, Katren, Puls, Rosta, Alliance Healthcare, Pharmkomplekt, Implozia) ● Russian and International manufacturers and suppliers of raw materials
  • 17. 17 Contacts Headquarter: 25/1, pereulok Oruzheyniy, Moscow, 125047 www.piqpharma.com E-mail: info@pikfarma.ru tel.: +7-495-925-57-00 Video channel: Youtube.com/pikfarma 17